search
Back to results

Erbium Chromium: YSGG Laser Effect on Surgical Treatment of Chronic Periodontitis

Primary Purpose

Generalized Chronic Periodontitis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
laser device Er,Cr:YSGG laser
Sponsored by
alaa
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Generalized Chronic Periodontitis

Eligibility Criteria

25 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients are diagnosed to have chronic periodontitis, having infrabony posterior periodontal pocket measuring 5 mm or more.
  • female or male.
  • 25 - 55 years.
  • Medically controlled according to medical coding of review of systems .
  • Patient without history of drug administration in last month .

Exclusion criteria:

  • Tobacco smoking.
  • Pregnancy.
  • Patients not follow periodontal hygienic instructions.
  • Patients under any medication that affect periodontal healing.
  • The presence of any systemic disease that affect periodontal healing.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Active Comparator

    Arm Label

    open flap debridement

    laser device with open flap debridement

    Arm Description

    surgical treatment of periodontal pocket without any intervention

    surgical intervention associated with application of Erbium chromium: YSGG laser therapy

    Outcomes

    Primary Outcome Measures

    Clinical Assessment of Plaque index(PI)
    Visual Analog Score for plaque for detection amount of plaque accumulation so assess patient oral hygiene. recording is based on both soft and mineralized debris. Each surface will have a score from 0 to 3. 0: no plaque plaque only detected by probe. Moderate deposits detected by naked eye. heavy deposits detected by naked eye.
    Clinical Assessment of Gingival index(GI) to assess gingival inflammation. 0: normal gingiva. 1: mild inflammation . 2: moderate inflammation . 3: sever inflammation marked redness and edema and spontaneous bleeding.
    Visual Analog Score for gingival inflammation
    Clinical Assessment of Probing depth (PD).
    measured by milli meters for detection of level of periodontal destruction.
    Clinical Assessment of Clinical attachment level (CAL) .
    measured by milli meters for detection of level of periodontal destruction.
    Clinical Assessment of Gingival recession(GR)
    measured by milli meters for detection of level of apical migration of gingival attachment.
    Clinical Assessment of Modified sulcular bleeding index (MSBI)
    Visual Analog Score of bleeding for detection of inflammatory status level. Modified Sulcus Bleeding Index(MSBI) 0 = No bleeding on bleeding. =pin pointed bleeding. = linear bleeding. = Heavy or profuse bleeding.

    Secondary Outcome Measures

    Microbiological assessment through real time PCR assay for quantification of total bacterial load by universal probe and primer set (16sr RNA)
    quantification of total bacterial load

    Full Information

    First Posted
    January 5, 2019
    Last Updated
    March 4, 2023
    Sponsor
    alaa
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03810560
    Brief Title
    Erbium Chromium: YSGG Laser Effect on Surgical Treatment of Chronic Periodontitis
    Official Title
    Microbiological and Clinical Assessments of Erbium Chromium: YSGG Laser as an Adjunctive to Surgical Treatment of Chronic Periodontitis (Randomized Clinical Trial)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2023
    Overall Recruitment Status
    Completed
    Study Start Date
    December 2016 (Actual)
    Primary Completion Date
    January 2019 (Actual)
    Study Completion Date
    April 2019 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    alaa

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Microbiological and Clinical assessment of Er,Cr:YSGG laser in conjunction to open flap debridement (OFD) in treatment of chronic periodontitis through real time PCR assay for quantification of total bacterial load.
    Detailed Description
    Two groups are randomly allocated (random number generation) by Microsoft excel into two groups : Group (1) Open Flap debridement (OFD) surgery after conventional periodontal therapy (Scaling &Curettage and root planing) combined by Er,Cr:YSGG Laser assisted pocket therapy (ELAPT) which will be applied to pocket epithelial lining and root surface. Group (2) Open Flap debridement (OFD) surgery after conventional periodontal therapy (Scaling &Curettage and root planing) will be performed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Generalized Chronic Periodontitis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    34 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    open flap debridement
    Arm Type
    No Intervention
    Arm Description
    surgical treatment of periodontal pocket without any intervention
    Arm Title
    laser device with open flap debridement
    Arm Type
    Active Comparator
    Arm Description
    surgical intervention associated with application of Erbium chromium: YSGG laser therapy
    Intervention Type
    Device
    Intervention Name(s)
    laser device Er,Cr:YSGG laser
    Intervention Description
    laser device with open flap debridement
    Primary Outcome Measure Information:
    Title
    Clinical Assessment of Plaque index(PI)
    Description
    Visual Analog Score for plaque for detection amount of plaque accumulation so assess patient oral hygiene. recording is based on both soft and mineralized debris. Each surface will have a score from 0 to 3. 0: no plaque plaque only detected by probe. Moderate deposits detected by naked eye. heavy deposits detected by naked eye.
    Time Frame
    6 months
    Title
    Clinical Assessment of Gingival index(GI) to assess gingival inflammation. 0: normal gingiva. 1: mild inflammation . 2: moderate inflammation . 3: sever inflammation marked redness and edema and spontaneous bleeding.
    Description
    Visual Analog Score for gingival inflammation
    Time Frame
    6 months
    Title
    Clinical Assessment of Probing depth (PD).
    Description
    measured by milli meters for detection of level of periodontal destruction.
    Time Frame
    6 months
    Title
    Clinical Assessment of Clinical attachment level (CAL) .
    Description
    measured by milli meters for detection of level of periodontal destruction.
    Time Frame
    6 months
    Title
    Clinical Assessment of Gingival recession(GR)
    Description
    measured by milli meters for detection of level of apical migration of gingival attachment.
    Time Frame
    6 months
    Title
    Clinical Assessment of Modified sulcular bleeding index (MSBI)
    Description
    Visual Analog Score of bleeding for detection of inflammatory status level. Modified Sulcus Bleeding Index(MSBI) 0 = No bleeding on bleeding. =pin pointed bleeding. = linear bleeding. = Heavy or profuse bleeding.
    Time Frame
    6 months
    Secondary Outcome Measure Information:
    Title
    Microbiological assessment through real time PCR assay for quantification of total bacterial load by universal probe and primer set (16sr RNA)
    Description
    quantification of total bacterial load
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    25 Years
    Maximum Age & Unit of Time
    55 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Patients are diagnosed to have chronic periodontitis, having infrabony posterior periodontal pocket measuring 5 mm or more. female or male. 25 - 55 years. Medically controlled according to medical coding of review of systems . Patient without history of drug administration in last month . Exclusion criteria: Tobacco smoking. Pregnancy. Patients not follow periodontal hygienic instructions. Patients under any medication that affect periodontal healing. The presence of any systemic disease that affect periodontal healing.

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Erbium Chromium: YSGG Laser Effect on Surgical Treatment of Chronic Periodontitis

    We'll reach out to this number within 24 hrs